Clinical Trials in Maryland

Showing 19881-19900 of 23,284 trials

Clinical Trial in Females for Female Pattern Hair Loss

NCT01226459

This is a six month clinical trial to evaluate the effectiveness and safety in women with Female Pattern Hair Loss (FPHL), comparing a 5% minoxidil topical foam (MTF) formulation applied once a day versus a topical foam vehicle (placebo) formulation applied once a day.

Androgenetic Alopecia

Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.404 participantsStarted Sep 2010

Los Angeles, California, United States • Los Angeles, California, United States • San Diego, California, United States +14 more locations

COMPLETED12 miles

Patient Registry Study of Berinert® in Normal Clinical Practice

NCT01108848

The objective of this patient registry is to collect data on the safety of Berinert® in normal clinical practice in the United States. The patient registry will be maintained for a period of at least 3 years. The duration of individual patient participation will vary and is determined by the frequency of hereditary angioedema (HAE) attacks and the patient's need for Berinert® treatment.

Includes: Hereditary Angioedema

CSL Behring318 participantsStarted Apr 2010

Scottsdale, Arizona, United States • Granada Hills, California, United States • Los Angeles, California, United States +37 more locations

Clinical Trial in Females for Female Pattern Hair Loss

Patient Registry Study of Berinert® in Normal Clinical Practice

Find Trials by Condition in Maryland

RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial

Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia

Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty

Development of Cockroach Immunotherapy by the Inner-City Asthma Consortium

Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer

Single Ascending-dose Study of the Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Subjects

Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery

Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia

Pramipexole ER vs. Placebo in Fibromyalgia

Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases

12 / 48 Week Pivotal PFT vs PBO in COPD I

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

Enhancing the Prospective Prediction of Psychosis

Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification

A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022

Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis

Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy